Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by skys1on Sep 21, 2021 1:50pm
737 Views
Post# 33892959

RE:RE:RE:RE:RE:RE:RE:TLD1433 and Conjunctive Melanoma (CM)

RE:RE:RE:RE:RE:RE:RE:TLD1433 and Conjunctive Melanoma (CM)Just my opinion in regards funding etc, however I do know there is very strong outsde interest in the virus killing abilities of 1433. I don't believe there will be a need for another PP financing as we now have a couple very valuable relationships with well healed enities we didn't have previously. A. The  Canadian gov's level 4 biolab is researching on the possibilities of a virus vaccine using 1433. The gov. is always giving out grants etc for medical research by Canadian entities and in this case they are already a partner of sorts in 1433 virus research so it is a natural. B. TLT's research lab is now on the premise of St Mikes. There is no way that relationship would have occured if there wasn't strong intetest in TLT's ACT and 1433 virus research. St Mikes/Unity Health is part of an organization that has already granted funds of over $3 BILLION for worthwhile medical research by independant entities. TlT's needs would be miniscule next to that sum. In short, when the financial assistance becomes neccessary, I believe one of their patners will step up with the needed funds.
<< Previous
Bullboard Posts
Next >>